1. Home
  2. BCO vs LGND Comparison

BCO vs LGND Comparison

Compare BCO & LGND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Brinks Company (The)

BCO

Brinks Company (The)

HOLD

Current Price

$116.60

Market Cap

4.7B

ML Signal

HOLD

Logo Ligand Pharmaceuticals Incorporated

LGND

Ligand Pharmaceuticals Incorporated

HOLD

Current Price

$184.97

Market Cap

3.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BCO
LGND
Founded
1859
1987
Country
United States
United States
Employees
N/A
68
Industry
Oil Refining/Marketing
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.7B
3.9B
IPO Year
N/A
1992

Fundamental Metrics

Financial Performance
Metric
BCO
LGND
Price
$116.60
$184.97
Analyst Decision
Strong Buy
Analyst Count
0
8
Target Price
N/A
$144.71
AVG Volume (30 Days)
244.1K
139.7K
Earning Date
11-05-2025
08-05-2025
Dividend Yield
0.87%
N/A
EPS Growth
49.50
N/A
EPS
3.95
N/A
Revenue
$5,146,400,000.00
$181,488,000.00
Revenue This Year
$5.53
$18.41
Revenue Next Year
$4.97
$18.87
P/E Ratio
$29.74
N/A
Revenue Growth
3.07
53.40
52 Week Low
$80.10
$81.74
52 Week High
$118.60
$129.90

Technical Indicators

Market Signals
Indicator
BCO
LGND
Relative Strength Index (RSI) 59.87 38.34
Support Level $111.50 $192.71
Resistance Level $118.31 $201.49
Average True Range (ATR) 2.96 6.84
MACD 0.77 -2.89
Stochastic Oscillator 84.76 3.79

Price Performance

Historical Comparison
BCO
LGND

About BCO Brinks Company (The)

The Brink's Co is a provider of secure logistics and security solutions for cash and other valuables. Its segments include: North America segment includes operations in the U.S. and Canada, including the Brink's Global Services (BGS) line of business; Latin America segment consists operations in Latin American countries where it has an ownership interest, including the BGS line of business; Europe segment includes total operations in European countries that provide services outside of the BGS line of business; and Rest of World segment consists operations in the Middle East, Africa and Asia. It also includes total operations in European countries that provides BGS services and BGS activity in Latin American countries. It derives maximum revenue from North America segment.

About LGND Ligand Pharmaceuticals Incorporated

Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.

Share on Social Networks: